<bill session="106" type="h" number="4242" updated="2013-07-14T18:54:45-04:00">
  <state datetime="2000-04-11">REFERRED</state>
  <status>
    <introduced datetime="2000-04-11"/>
  </status>
  <introduced datetime="2000-04-11"/>
  <titles>
    <title as="introduced" type="short">Orphan Drug Innovation Act</title>
    <title as="introduced" type="official">To amend section 527 of the Federal Food, Drug and Cosmetic Act with respect to clinically superior modifications to previously approved or licensed drugs.</title>
  </titles>
  <sponsor id="400404"/>
  <cosponsors>
    <cosponsor id="400099" joined="2000-07-19"/>
    <cosponsor id="400307" joined="2000-05-22"/>
    <cosponsor id="400327" joined="2000-05-02"/>
    <cosponsor id="400432" joined="2000-05-24"/>
  </cosponsors>
  <actions>
    <action state="REFERRED" datetime="2000-04-11">
      <text>Referred to the House Committee on Commerce.</text>
    </action>
    <action datetime="2000-04-24">
      <text>Referred to the Subcommittee on Health and Environment.</text>
      <committee name="House Committee on Commerce"/>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Commerce" activity="Referral, In Committee"/>
    <committee activity="Referral" code="HSIF04" subcommittee="Health and Environment" name="House Commerce"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Drug approvals"/>
    <term name="Law"/>
    <term name="Licenses"/>
    <term name="Orphan drugs"/>
  </subjects>
  <amendments/>
  <summary>4/11/2000--Introduced.
Orphan Drug Innovation Act - Amends the Federal Food, Drug and Cosmetic Act, with respect to orphan drugs, to provide for the waiver of the seven-year prohibition against approval for a drug which is clinically superior to an approved drug.</summary>
</bill>
